Free Trial

OSR (OSRH) Competitors

OSR logo
$1.33 -0.02 (-1.48%)
As of 04/17/2025 04:00 PM Eastern

OSRH vs. DRIO, RVP, NEPH, NXGL, PTHL, QTI, XAIR, IRIX, LFWD, and NMTC

Should you be buying OSR stock or one of its competitors? The main competitors of OSR include DarioHealth (DRIO), Retractable Technologies (RVP), Nephros (NEPH), NEXGEL (NXGL), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), QT Imaging (QTI), Beyond Air (XAIR), IRIDEX (IRIX), ReWalk Robotics (LFWD), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry.

OSR vs.

OSR (NASDAQ:OSRH) and DarioHealth (NASDAQ:DRIO) are both small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking.

OSR has higher revenue and earnings than DarioHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OSR$4.89B0.00N/AN/AN/A
DarioHealth$27.04M1.15-$59.43M-$0.62-1.21

OSR has a net margin of 0.00% compared to DarioHealth's net margin of -205.62%. OSR's return on equity of 0.00% beat DarioHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
OSRN/A N/A N/A
DarioHealth -205.62%-72.16%-40.74%

In the previous week, DarioHealth had 2 more articles in the media than OSR. MarketBeat recorded 2 mentions for DarioHealth and 0 mentions for OSR. DarioHealth's average media sentiment score of 0.34 beat OSR's score of 0.00 indicating that DarioHealth is being referred to more favorably in the news media.

Company Overall Sentiment
OSR Neutral
DarioHealth Neutral

DarioHealth received 239 more outperform votes than OSR when rated by MarketBeat users.

CompanyUnderperformOutperform
OSRN/AN/A
DarioHealthOutperform Votes
239
66.95%
Underperform Votes
118
33.05%

55.3% of OSR shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 33.7% of OSR shares are owned by insiders. Comparatively, 10.9% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

OSR has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

DarioHealth has a consensus target price of $1.50, indicating a potential upside of 100.00%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts plainly believe DarioHealth is more favorable than OSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DarioHealth
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

DarioHealth beats OSR on 8 of the 14 factors compared between the two stocks.

Get OSR News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSRH vs. The Competition

MetricOSRHolding Offices Industry SectorNASDAQ Exchange
Market Cap$5.38M$458.12M$2.35B$7.34B
Dividend YieldN/A8.15%13.20%4.30%
P/E RatioN/A2.4010.9317.80
Price / Sales0.0059.123,358,974.6497.74
Price / CashN/A69.0157.1134.64
Price / BookN/A3.663.273.98
Net IncomeN/A$35.22M-$322.08M$247.81M
7 Day Performance-7.64%3.00%0.50%1.80%
1 Month Performance-25.70%0.22%-3.99%-6.81%
1 Year PerformanceN/A19.91%2.94%1.31%

OSR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSRH
OSR
N/A$1.33
-1.5%
N/AN/A$5.38M$4.89B0.00N/A
DRIO
DarioHealth
2.1325 of 5 stars
$0.73
+30.5%
$1.50
+106.7%
-38.0%$23.11M$27.04M-0.77200News Coverage
Gap Up
High Trading Volume
RVP
Retractable Technologies
N/A$0.68
-5.9%
N/A-31.9%$20.36M$33.05M-1.26240
NEPH
Nephros
1.7241 of 5 stars
$1.90
flat
$5.00
+163.2%
-1.6%$20.14M$14.16M-21.1130Positive News
Gap Up
NXGL
NEXGEL
0.4284 of 5 stars
$2.54
-2.3%
N/A+26.3%$19.44M$8.69M-4.3810Short Interest ↑
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/A$2.93
-3.9%
N/AN/A$19.29M$448,196.000.0011Positive News
QTI
QT Imaging
N/A$0.60
-0.1%
N/A-12.1%$16.28M$4.00M0.00N/AGap Up
XAIR
Beyond Air
4.217 of 5 stars
$0.24
+2.7%
$3.67
+1,452.4%
-81.3%$16.25M$3.02M-0.2270
IRIX
IRIDEX
1.3541 of 5 stars
$0.94
-0.6%
$2.00
+112.2%
-67.9%$15.92M$48.67M-1.41120Analyst Forecast
LFWD
ReWalk Robotics
2.6542 of 5 stars
$1.43
+2.9%
$9.00
+529.4%
-71.6%$15.20M$25.66M-0.5760Short Interest ↓
Positive News
Gap Down
NMTC
NeuroOne Medical Technologies
0.2775 of 5 stars
$0.47
+9.3%
N/A-50.8%$14.51M$5.75M-1.8120News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:OSRH) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners